Current role and affiliation
Emilie Meyer Bull has been a member of the K.G. Jebsen Academy for Young Medical Researchers since 2026. She is a clinical psychologist and postdoctoral researcher at Lovisenberg Diaconal Hospital, having completed her PhD at the K.G. Jebsen Centre for Neurodevelopmental Disorders, University of Oslo, in 2025.
Meyer Bull leads several externally funded research projects and collaborates with multiple research groups:
- Lovisenberg Diaconal Hospital: Where she leads a randomised controlled trial of adapted group therapy for anxiety and depression in adults with an autism spectrum diagnosis. She is also working on clinical service development at a specialised clinic for adults with ADHD, autism and other neurodevelopmental conditions at the Centre for Mental Health and Substance Use.
- Telemark Hospital Trust: Within child and adolescent mental health services, she works clinically and leads a study of adapted group therapy for anxiety and depression in adolescents with an autism spectrum diagnosis.
- Department of Neurohabilitation, Oslo University Hospital: Here, she conducts research on fatigue in neurodevelopmental conditions and leads the further development of technology from her doctoral research, in collaboration with the University of Oslo.
- Oslo Behavioural Neuroendocrinology Lab (BNL), University of Oslo: Where she investigates the effects of oxytocin on neuroplasticity and cognitive flexibility in adolescents with an autism spectrum diagnosis.
Research interests and focus
Emilie Meyer Bull's research focuses on improving our understanding, assessment and treatment of mental and neurological health problems in people with mental illness or neurodevelopmental conditions. Her research has three main strands:
- Adapted psychotherapy: Her research investigates whether group-based cognitive behavioural therapy, adapted for people with an autism spectrum diagnosis, can reduce anxiety and depression in adults and adolescents. She also explores how participants themselves experience the treatment.
- Biological mechanisms: In her postdoctoral project, she analyses data from a biobank and research register in child and adolescent psychiatry. She investigates the mechanisms of action of the hormone oxytocin and uses EEG and FDG-PET in approximately 250 patients to identify brain characteristics associated with fatigue.
- Technology for more equitable healthcare: Meyer Bull leads the development of sensor technology and an app designed to make it easier to detect pain in people who are seriously ill and cannot communicate clearly.
What unites these projects is the aim of linking clinically relevant questions with biological measures, so that research can contribute to better and more tailored health services.
Selected publications
- Ethical and practical concerns of heart rate monitoring: Enabling communication for patients with severe communication difficulties.
Bull, Emilie Meyer, Hofmann, Bjørn, Nærland, Terje, Andreassen, Ole A., Quintana, Daniel S., and Hassel, Bjørnar. Clinical Ethics 20, no. 3 (2025): 170-181 - Using EEG to measure the neural effects of oxytocin administration: A meta-analysis and systematic review.
Deilhaug, Elisabeth, Moerkerke, Matthijs, Sartorius, Alina I., Kang, Heemin, Bull, Emilie Meyer, Walle, Kjersti M., Elvsåshagen, Torbjørn, Westlye, Lars T., Nærland, Terje, Andreassen, Ole A., and Quintana, Daniel S.
Psychophysiology 63, no. 6 (2026): e70334